Food and Drug Administration Briefing Package Table of Contents

Letter to the Committee Members from Deputy Director, Division of Reproductive Health and Urologic Drug Products, FDA 

FDA Review Package for the Advisory Committee

The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

TAP Holdings Inc Briefing Information